102
Participants
Start Date
July 29, 2022
Primary Completion Date
October 13, 2026
Study Completion Date
January 30, 2027
DWN12088
DWN12088 Xmg Tablet (BID)
Placebo
Placebo 0mg Tablet (BID)
RECRUITING
Myongji Hospital, Goyang-si
RECRUITING
Soon Chun Hyang University Hospital Bucheon, Bucheon-si
RECRUITING
The Catholic University of Korea, Bucheon St. Mary's Hospital, Bucheon-si
RECRUITING
University of Pittsburgh Medical Center, Pittsburgh
RECRUITING
Ajou University Hospital, Hwaseong-si
RECRUITING
Penn State Milton S. Hershey Medical Center, Hershey
RECRUITING
Pulmonix Research, LLC, Greensboro
RECRUITING
Duke University Medical Center, Durham
RECRUITING
The U.S. Department of Veterans Affairs, Charleston
RECRUITING
Lowcountry Lung and Critical Care, Charleston
RECRUITING
Ulsan University Hospital, Ulsan
RECRUITING
Inje University Busan Paik Hospital, Busan
RECRUITING
University of Michigan Health System, Michigan Center
RECRUITING
Loyola University Medical Center (LUMC), Maywood
RECRUITING
The Lung Research Center, LLC, Chesterfield
RECRUITING
University of Kansas Medical Center Research Institute, Inc, Kansas City
RECRUITING
Baylor Scott & White Research Institute, Dallas
RECRUITING
Baylor College of Medicine, Houston
RECRUITING
Dignity Health Norton Thoracic Institute, Phoenix
RECRUITING
The University of California San Francisco, San Francisco
RECRUITING
Legacy Research Institute, Portland
RECRUITING
Pulmonary Associates, PA, Mesa
RECRUITING
Tufts Medical Center, Boston
RECRUITING
Beth Israel Deaconess Medical Center, Boston
RECRUITING
The University of Texas Southwestern Medical Center, Dallas
RECRUITING
The University of Texas Health San Antonio Medical Arts & Research Center, San Antonio
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Severance Hospital, Yonsei University Health System, Seoul
RECRUITING
Asan Medical Center, Seoul
RECRUITING
Samsung Medical Center, Seoul
Lead Sponsor
Daewoong Pharmaceutical Co. LTD.
INDUSTRY